Real-Time Intracellular Ca2+ Mobilization by Travoprost Acid, Bimatoprost, Unoprostone, and Other Analogs via Endogenous Mouse, Rat, and Cloned Human FP Prostaglandin Receptors

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Journal of Pharmacology and Experimental Therapeutics

• Publication date

  2003-01-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1124/jpet.102.042556PMID 12490597
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Agonist Activity of Bimatoprost, Travoprost, Latanoprost, Unoprostone Isopropyl Ester and Other Prostaglandin Analogs at the Cloned Human Ciliary Body FP Prostaglandin Receptor

  2002influential reference
• Bimatoprost Hydrolysis to 17-Phenyl PGF2alpha by Human and Rabbit Ocular Tissues and Agonist Activity of Bimatoprost and 17-Phenyl PGF2alpha

  2002influential reference
• The hydrolysis of bimatoprost in corneal tissue generates a potent prostanoid FP receptor agonist.

  2002cited by this paper
• Bimatoprost and its free acid are prostaglandin FP receptor agonists.

  2001influential reference
• Studies on Receptor Binding and Signal Transduction Pathways of Unoprostone Isopropyl

  2001cited by this paper
• The pharmacology of bimatoprost (Lumigan).

  2001cited by this paper
• Key structural features of prostaglandin E(2) and prostanoid analogs involved in binding and activation of the human EP(1) prostanoid receptor.

  2001cited by this paper
• Preclinical Efficacy of Travoprost, a Potent and Selective FP Prostaglandin Receptor Agonist

  2001cited by this paper
• The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs.

  2000cited by this paper
• Characterization using FLIPR of rat vanilloid receptor (rVR1) pharmacology

  2000cited by this paper
• AL‐3138 Antagonizes FP Prostanoid Receptor‐mediated Inositol Phosphates Generation: Comparison with Some Purported FP Antagonists

  2000cited by this paper
• AL-8810: a novel prostaglandin F2 alpha analog with selective antagonist effects at the prostaglandin F2 alpha (FP) receptor.

  1999cited by this paper
• Measurement of [Ca2+] using the Fluorometric Imaging Plate Reader (FLIPR).

  1999cited by this paper
• AL-8810: A Novel Prostaglandin F2α Analog with Selective Antagonist Effects at the Prostaglandin F2α (FP) Receptor

  1999influential reference
• Pharmacology of [3H]prostaglandin E1/[3H]prostaglandin E2 and [3H]prostaglandin F2alpha binding to EP3 and FP prostaglandin receptor binding sites in bovine corpus luteum: characterization and correlation with functional data.

  1998influential reference
• Pharmacological characterization of an FP prostaglandin receptor on rat vascular smooth muscle cells (A7r5) coupled to phosphoinositide turnover and intracellular calcium mobilization.

  1998cited by this paper
• FP prostaglandin receptors mediating inositol phosphates generation and calcium mobilization in Swiss 3T3 cells: a pharmacological study.

  1997cited by this paper
• Functional characterization of the ocular prostaglandin f2alpha (PGF2alpha) receptor. Activation by the isoprostane, 12-iso-PGF2alpha.

  1997cited by this paper
• Prostaglandins: a new approach to glaucoma management with a new, intriguing side effect.

  1997cited by this paper
• Ocular Hypotensive Mechanism of Topical Isopropyl Unoprostone, a Novel Prostaglandin Metabolite-Related Drug, in Rabbits

  1996cited by this paper
• Preclinical pharmacology of latanoprost, a phenyl-substituted PGF2 alpha analogue.

  1995cited by this paper
• Preclinical pharmacology of latanoprost, a phenyl-substituted PGF2a analogue

  1995cited by this paper
• Identification of a single (FP) receptor associated with prostanoid-induced Ca2+ signals in Swiss 3T3 cells.

  1994cited by this paper
• Effects of prostaglandins F2 alpha, A2, and their esters in glaucomatous monkey eyes.

  1990cited by this paper

• Safety and efficacy of travoprost intracameral implant administered in combination with cataract surgery

  2025cites this paper
• Prostanoid receptors in GtoPdb v.2025.3

  2025cites this paper
• FP and EP2 prostanoid receptor agonist drugs and aqueous humor outflow devices for treating ocular hypertension and glaucoma.

  2023cites this paper
• Recently Approved Drugs for Lowering and Controlling Intraocular Pressure to Reduce Vision Loss in Ocular Hypertensive and Glaucoma Patients

  2023cites this paper
• Prostanoid receptors in GtoPdb v.2021.2

  2021cites this paper
• Therapeutic Drugs and Devices for Tackling Ocular Hypertension and Glaucoma, and Need for Neuroprotection and Cytoprotective Therapies

  2021cites this paper
• Medical Management of Glaucoma

  2020cites this paper
• Pharmacodynamic Evaluation: Ocular Pharmacology

  2020cites this paper
• Discovery to Launch of Anti-allergy (Emadine; Patanol/Pataday/Pazeo) and Anti-glaucoma (Travatan; Simbrinza) Ocular Drugs, and Generation of Novel Pharmacological Tools Such as AL-8810.

  2020cites this paper
• Research, Discovery and Development of Novel Therapeutics for the EyeDiseases Allergic Conjunctivitis and Glaucoma

  2020cites this paper
• Discovery, characterization and clinical utility of prostaglandin agonists for the treatment of glaucoma

  2019cites this paper
• Prostanoid receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database

  2019cites this paper
• iDrugs and iDevices Discovery Research: Preclinical Assays, Techniques, and Animal Model Studies for Ocular Hypotensives and Neuroprotectants

  2018cites this paper
• Kobe University Repository : Kernel タイトル Tit le Latanoprost rescues ret inal neuro-glial cells from apoptosis by inhibit ing caspase-3 , which is mediated by p 44 / p 42 mitogen-act ivated protein kinase

  2018cites this paper
• Prostaglandin FP receptor antagonists: discovery, pharmacological characterization and therapeutic utility

  2018cites this paper
• Ocular Hypotensive Activity of a Non-Peptide Bradykinin B2-Receptor Antagonist (WIN-64338) In Dutch-Belt Rabbits- A Case of Poly-Pharmacology in Action

  2015cites this paper
• Unoprostone activation of BK (KCa1.1) channel splice variants.

  2015cites this paper
• Human Non-Pigmented Ciliary Epithelium Bradykinin B2-Receptors: Receptor Localization, Pharmacological Characterization of Intracellular Ca2+ Mobilization, and Prostaglandin Secretion

  2014cites this paper
• Trabecular Meshwork Bradykinin Receptors: mRNA Levels, Immunohistochemical Visualization, Signaling Processes Pharmacology, and Linkage to IOP Reduction

  2014cites this paper
• Preclinical pharmacology, ocular tolerability and ocular hypotensive efficacy of a novel non-peptide bradykinin mimetic small molecule.

  2014cites this paper
• FR‐190997, a Nonpeptide Bradykinin B2‐Receptor Partial Agonist, is a Potent and Efficacious Intraocular Pressure Lowering Agent in Ocular Hypertensive Cynomolgus Monkeys

  2014cites this paper
• Possible mechanism for the gastro-intestinal adverse effects upon topical application of Prostaglandin F₂α analogs.

  2013cites this paper
• Protein expression, biochemical pharmacology of signal transduction, and relation to intraocular pressure modulation by bradykinin B2 receptors in ciliary muscle

  2013cites this paper
• Therapeutic uses of prostaglandin F(2α) analogues in ocular disease and novel synthetic strategies.

  2013cites this paper
• Eicosanoids and Renal Function

  2013cites this paper
• Unoprostone isopropyl and metabolite M1 activate BK channels and prevent ET-1-induced [Ca²⁺]i increases in human trabecular meshwork and smooth muscle.

  2012influential citation
• Unoprostone reduces oxidative stress- and light-induced retinal cell death, and phagocytotic dysfunction, by activating BK channels

  2011cites this paper
• Aqueous Humor Concentrations of Bimatoprost Free Acid, Bimatoprost and Travoprost Free Acid in Cataract Surgical Patients Administered Multiple Topical Ocular Doses of LUMIGAN® or TRAVATAN®

  2010cites this paper
• Bimatoprost-Induced Calcium Signaling in Human T-Cells does not Involve Prostanoid FP or TP Receptors

  2009cites this paper
• Pharmacological properties and discriminative stimulus effects of a novel and selective 5-HT2 receptor agonist AL-38022A [(S)-2-(8,9-dihydro-7H-pyrano[2,3-g]indazol-1-yl)-1-methylethylamine].

  2009cites this paper
• Update and commentary on the pro-drug bimatoprost and a putative ‘prostamide receptor’

  2009cites this paper
• Cabergoline: Pharmacology, ocular hypotensive studies in multiple species, and aqueous humor dynamic modulation in the Cynomolgus monkey eyes.

  2009cites this paper
• Expression and functional evidence of the prostaglandin F2alpha receptor mediating contraction in human umbilical vein.

  2009cites this paper
• Bimatoprost, the prodrug of a prostaglandin analogue.

  2008cites this paper
• PGF2alpha-associated vascular smooth muscle hypertrophy is ROS dependent and involves the activation of mTOR, p70S6k, and PTEN.

  2008cites this paper
• DP Prostanoid Receptor

  2008cites this paper
• Synthetic FP-prostaglandin-induced contraction of rat uterus smooth muscle in vitro.

  2008cites this paper
• Maggot therapy for periocular skin graft failure in the immunocompromised patient

  2008cites this paper
• Commercially available prostaglandin analogs for the reduction of intraocular pressure: similarities and differences.

  2008cites this paper
• Cat Iris Sphincter Smooth-Muscle Contraction: Comparison of FP-Class Prostaglandin Analog Agonist Activities

  2008cites this paper
• Cellular and molecular effects of unoprostone as a BK channel activator.

  2007cites this paper
• RESEARCH PAPER Insulin induces airway smooth muscle contraction

  2007cites this paper
• Identification of an antagonist that selectively blocks the activity of prostamides (prostaglandin‐ethanolamides) in the feline iris

  2007cites this paper
• Travoprost in the management of open-angle glaucoma and ocular hypertension

  2007cites this paper
• AL-34662: A Potent, Selective, And Efficacious Ocular Hypotensive Serotonin-2 Receptor Agonist

  2007cites this paper
• Evidence for the involvement of cannabinoid CB1 receptors in the bimatoprost-induced contractions on the human isolated ciliary muscle.

  2007cites this paper
• Mechanism of unoprostone-induced cytosolic Ca2+ mobility in cultured porcine corneal endothelial cells.

  2007cites this paper
• Insulin induces airway smooth muscle contraction

  2007cites this paper
• Effect of 15-keto latanoprost on intraocular pressure and aqueous humor dynamics in monkey eyes.

  2007cites this paper
• Serotonin-2 (5-HT2) Receptor-Mediated Signal Transduction in Human Ciliary Muscle Cells: Role in Ocular Hypotension

  2006cites this paper
• Pharmacological Evidence for a Functional Serotonin-2B Receptor in a Human Uterine Smooth Muscle Cell Line

  2006cites this paper
• Human trabecular meshwork cells express functional serotonin-2A (5HT2A) receptors: role in IOP reduction.

  2006cites this paper
• Travoprost compared with other prostaglandin analogues or timolol in patients with open‐angle glaucoma or ocular hypertension: meta‐analysis of randomized controlled trials

  2006cites this paper
• Preclinical Pharmacology of AL-12182, a New Ocular Hypotensive 11-Oxa Prostaglandin Analog

  2006influential citation
• 1-((S)-2-aminopropyl)-1H-indazol-6-ol: a potent peripherally acting 5-HT2 receptor agonist with ocular hypotensive activity.

  2006cites this paper
• Latanoprost rescues retinal neuro-glial cells from apoptosis by inhibiting caspase-3, which is mediated by p44/p42 mitogen-activated protein kinase.

  2006cites this paper
• Pharmacological Evidence for a Functional Serotonin-2 B ( 5-HT 2 B ) Receptor in a Human Uterine Smooth Muscle Cell Line

  2006cites this paper
• Inhibition of Direct Prostaglandin F 2α Effects on Pre-attachment Embryos Improves Reproductive Efficiency in Cattle

  2006cites this paper
• Bimatoprost: a novel antiglaucoma agent.

  2006cites this paper
• Travoprost/Timolol

  2006cites this paper
• Efficacy and safety of a fixed combination of travoprost 0.004%/timolol 0.5% ophthalmic solution once daily for open-angle glaucoma or ocular hypertension.

  2005cites this paper
• Effect of bimatoprost on intraocular pressure in prostaglandin FP receptor knockout mice.

  2005cites this paper
• Characterization of a Rabbit Kidney Prostaglandin F2α Receptor Exhibiting Gi-restricted Signaling That Inhibits Water Absorption in the Collecting Duct*

  2005cites this paper
• Role of contractile prostaglandins and Rho-kinase in growth factor-induced airway smooth muscle contraction

  2005cites this paper
• Pharmacology of the Oxidative Metabolites of Endocannabinoids

  2005cites this paper
• The glyceryl ester of prostaglandin E2 mobilizes calcium and activates signal transduction in RAW264.7 cells

  2004cites this paper
• Unoprostone isopropyl rescues retinal progenitor cells from apoptosis in vitro

  2004cites this paper
• Update on the mechanism of action of bimatoprost: a review and discussion of new evidence.

  2004cites this paper
• Detection of the free acid of bimatoprost in aqueous humor samples from human eyes treated with bimatoprost before cataract surgery.

  2004cites this paper
• Eficacia y seguridad de la solución oftálmica de travoprost en pacientes con glaucoma primario de ángulo abierto o hipertensión ocular

  2004cites this paper
• Prostaglandin E2 receptor subtypes, EP1, EP2, EP3 and EP4 in human and mouse ocular tissues--a comparative immunohistochemical study.

  2004cites this paper
• Intraocular Pressure Lowering Efficacy of Travoprost

  2004cites this paper
• A novel and selective 5-HT2 receptor agonist with ocular hypotensive activity: (S)-(+)-1-(2-aminopropyl)-8,9-dihydropyrano[3,2-e]indole.

  2003cites this paper
• Ocular Hypotensive FP Prostaglandin (PG) Analogs: PG Receptor Subtype Binding Affinities and Selectivities, and Agonist Potencies at FP and Other PG Receptors in Cultured Cells

  2003cites this paper
• Human Ciliary Muscle Cell Responses to FP-Class Prostaglandin Analogs: Phosphoinositide Hydrolysis, Intracellular Ca2+ Mobilization and MAP Kinase Activation

  2003cites this paper
• Effects of Prostaglandin F2α and Latanoprost on Phosphoinositide Turnover, Myosin Light Chain Phosphorylation and Contraction in Cat Iris Sphincter

  2003cites this paper
• Pharmacological characterization of prostanoid receptors mediating vasoconstriction in human umbilical vein

  2003cites this paper